This study demonstrates that circadian disruption exacerbates neuroinflammation, oxidative stress, and organ damage in Alzheimer’s disease, while Hif3α inhibition and BLFs offer partial protection. This evidence concerns the gene HIF3A and early-onset autosomal dominant Alzheimer disease.